Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort Study

被引:0
|
作者
Cheli Melzer Cohen
Nino Hallén
Gabriel Chodick
Lotmit Bourvine
Tal Waner
Avraham Karasik
机构
[1] Maccabi Healthcare Services,Maccabi Institute for Research and Innovation
[2] Novo Nordisk A/S,School of Public Health, Sackler Faculty of Medicine
[3] Tel Aviv University,Institute of Endocrinology
[4] Novo Nordisk A/S – Israel,undefined
[5] Chaim Sheba Medical Center,undefined
来源
PharmacoEconomics - Open | 2021年 / 5卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:533 / 544
页数:11
相关论文
共 50 条
  • [31] Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank
    Jin, Qiao
    Lau, Eric S. H.
    Luk, Andrea O. Y.
    Ozaki, Risa
    Chow, Elaine Y. K.
    Cheng, Feifei
    So, Tammy
    Yeung, Theresa
    Loo, Kit-man
    Lim, Cadmon K. P.
    Kong, Alice P. S.
    Jenkins, Alicia J.
    Chan, Juliana C. N.
    Ma, Ronald C. W.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (10)
  • [32] Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study
    Kathleen M. Fox
    Li Wang
    Shravanthi R. Gandra
    Ruben G. W. Quek
    Lu Li
    Onur Baser
    BMC Cardiovascular Disorders, 16
  • [33] Neonatal Short-Term Outcomes of Gestational Diabetes Mellitus in Saudi Mothers: A Retrospective Cohort Study
    Al-Khalifah, R.
    Al-Subaihin, A.
    Al-Kharfi, T.
    Al-Alaiyan, S.
    AlFaleh, Khalid M.
    JOURNAL OF CLINICAL NEONATOLOGY, 2012, 1 (01) : 29 - 33
  • [34] Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study
    Fox, Kathleen M.
    Wang, Li
    Gandra, Shravanthi R.
    Quek, Ruben G. W.
    Li, Lu
    Baser, Onur
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [35] DOES SHORT-TERM VITAMIN C REDUCE CARDIOVASCULAR RISK IN TYPE 2 DIABETES?
    Gutierrez, Absalon D.
    Duran-Valdez, Elizabeth
    Robinson, Irina
    de Serna, Daniela Gonzalez
    Schade, David S.
    ENDOCRINE PRACTICE, 2013, 19 (05) : 785 - 791
  • [36] Cost of cardiovascular disease events in patients with and without type 2 diabetes and factors influencing cost: a retrospective cohort study
    Puteh, Sharifa Ezat Wan
    Kamarudin, Noor 'Adilah
    Hussein, Zanariah
    Adam, Noorlita
    Shahari, Mohd Ridzwan
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [37] Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis
    Raju, Aditya
    Pimple, Pratik
    Stafkey-Mailey, Dana
    Farrelly, Eileen
    Shetty, Sharash
    DIABETES THERAPY, 2022, 13 (01) : 25 - 42
  • [38] Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis
    Aditya Raju
    Pratik Pimple
    Dana Stafkey-Mailey
    Eileen Farrelly
    Sharash Shetty
    Diabetes Therapy, 2022, 13 : 25 - 42
  • [39] Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
    Mcmanus, Emma
    Meacock, Rachel
    Parkinson, Beth
    Sutton, Matt
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2023, 21 (06) : 891 - 903
  • [40] Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
    Emma McManus
    Rachel Meacock
    Beth Parkinson
    Matt Sutton
    Applied Health Economics and Health Policy, 2023, 21 : 891 - 903